UBS AM’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
VCM
QF
PM
GI
UBS AM's ATEX Position: Q1 2026 in Review
UBS AM held its Anterix (ATEX) position steady in Q1 2026 at 13 shares worth $496. The position accounts for ﹤0.01% of the portfolio, ranked #3724.
UBS AM first reported a position in ATEX in Q1 2015 and has held it in 25 quarters since. The position peaked at $7.02M in Q1 2016. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.
- UBS AM held 13 shares of Anterix worth $496 as of Q1 2026.
- UBS AM left its Anterix share count unchanged in Q1 2026.
- Anterix made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #3724 holding.
- UBS AM first reported a position in Anterix in Q1 2015 and has held it in 25 quarters since.
- UBS AM's Anterix position peaked at $7.02M in Q1 2016.
- 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.
Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.